Treatment with LAU-7b, an oral form of fenretinide being developed by Laurent Pharmaceuticals, may help prevent lung function…
Articles by Marisa Wexler, MS
The improvements in lung function, respiratory symptoms, and nutritional status with Trikafta are stable after nearly three years in adolescents…
Six months of treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) led to significant improvements in lung function and a self-reported easing of…
Treatment with Trikafta leads to an increase in body weight and cholesterol levels among people with cystic fibrosis…
With continual advances in treatment, more people with cystic fibrosis (CF) are surviving well into adulthood and by 2040,…
Women and girls with cystic fibrosis (CF) who are being treated with antibiotics due to a pulmonary exacerbation tend…
CFTR modulators, a highly effective therapy for cystic fibrosis (CF), do not appear to affect fertility outcomes for men using them, data…
Note: This story was updated Nov. 9 to note that experiments done with Sionna’s CFTR modulators used a different investigational…
Exposure to tobacco smoke may reduce the effectiveness of Kalydeco (ivacaftor), a CFTR modulator that is widely approved to…
A novel scoring system may be used to classify the severity of lung disease among children with cystic fibrosis…